UK Chemists Call for Better Regulation of CBD Products

December 16, 2019 16:00:49

Very few products can claim to have risen from obscurity to extreme popularity as quickly as cannabidiol (CBD) has. The hemp extract is all the rage these days, and if you have been paying attention to the news, you’ve undoubtedly heard of it. The compound is extracted from industrial hemp, cannabis with minuscule levels of THC, and used in a variety of applications.

Undoubtedly, one of CBD’s most attractive aspects is its medicinal properties. Cannabidiol is one of the most potent and versatile natural medicines at the moment, and it’s used against a variety of diseases. For the past few years, users have used it with great success against…

Read More >>

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]

CBDWire is part of the InvestorBrandNetwork.